Bixink Therapeutics
Overview
BIXINK Therapeutics is a South Korean venture capital firm specializing in early-stage investments within the biotechnology and healthcare sectors. The firm focuses on identifying and supporting innovative companies that are developing cutting-edge treatments and technologies. By leveraging its expertise and network, BIXINK aims to foster the growth of promising startups in these industries. The firm's investment strategy encompasses a broad range of stages, including Seed, Early Stage, Series A, Series B, Growth, Late Stage, and Pre-IPO. This approach allows BIXINK to provide tailored support to companies at various points in their development, from initial concept to market readiness. The geographical focus of BIXINK spans multiple countries, including South Korea, the United States, China, Japan, Germany, France, the United Kingdom, Switzerland, Canada, Belgium, the Netherlands, Luxembourg, Finland, Austria, Poland, Denmark, Portugal, Sweden, Norway, and Italy. This extensive reach enables the firm to tap into diverse markets and identify global opportunities. BIXINK Therapeutics has a diverse portfolio of industries, reflecting its commitment to advancing various facets of the healthcare and biotechnology sectors. These include Biotechnology, Healthcare, Pharmaceuticals, Digital Therapeutics, Oncology, Mental Health, Medical Devices, Diagnostics, Medical Research, Biopharmaceuticals, Medical Technology, Clinical Trials, Regulatory Affairs, Health IT, and Medical Consulting. The firm's investment sizes range from $8.5 million to $38 million, indicating a capacity to support both emerging and more established companies in their growth trajectories.
Get the full list of 54,000+ investors
Bixink Therapeutics and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Bixink Therapeutics
What sectors does Bixink Therapeutics invest in?
Bixink Therapeutics invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Research, and is based in Seoul, South Korea. Bixink Therapeutics is listed as a venture capital in the ConnectSafely investor database.
What stage does Bixink Therapeutics invest at?
Bixink Therapeutics backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 8.5M - 38M.
Which regions does Bixink Therapeutics invest in?
Bixink Therapeutics invests across United States, United Kingdom, Canada, Germany, Japan and China.
Last updated · Source: ConnectSafely investor database

